Psychedelics & Monoamine Oxidase Inhibitors: DMT & 5-MeO-DMT
August 29 @ 6:30 pm - 9:00 pm
Monoamine Oxidase (MAO) is an important metabolic enzyme involved in the metabolism of several neurotransmitters and tryptamine psychedelics such as DMT and 5-MeO-DMT. While inhibition of this enzyme is critical to making DMT orally active as part of the mechanism of ayahuasca, it can be unsafe and even lethal to combine other drugs or psychedelics with MAO inhibitors (MAOIs). The third installment of the series will focus on the combination of monoamine oxidase inhibitors (MAOIs) with psychedelics as well as other drugs.
This is the third of a 5-part workshop series geared toward providing a foundation for understanding the psychopharmacology and clinical research of the most commonly encountered psychedelic compounds as well as practical information for safe psychedelic use. Seating is limited so sign up today!
Benjamin Malcolm teaches psychopharmacology, practices as a clinical psychiatric specialist, and performs research on psychoactive drugs including psychedelics. His educational background consists of a bachelor’s degree in pharmacology, a doctorate of pharmacy, a master’s degree in public health and specialized post-doctoral training in psychiatry. He’s a lover of nature, exercise, music and consciousness as well as being a husband and father. He’s passionate about psychedelic drugs and envisions a society in which they are available in safe and supported settings for psychospiritual well-being, personal growth, ceremonial sacrament, and treatment of mental illness. Additionally, he runs a psychopharmacology consulting service on his website, spiritpharmacist.com, to help those in need for an informational risk evaluation of psychedelic use.